AAAAAA
Results:
1-17
|
Results: 17
Authors:
ANDERSSON F
KARTMAN B
ANDERSSON OK
Citation: F. Andersson et al., COST-EFFECTIVENESS OF FELODIPINE-METOPROLOL (LOGIMAX(R)) AND ENALAPRIL IN THE TREATMENT OF HYPERTENSION, Clinical and experimental hypertension, 20(8), 1998, pp. 833-846
Authors:
BERGMAN H
ANDERSSON F
ISBERG A
Citation: H. Bergman et al., INCIDENCE OF TEMPOROMANDIBULAR-JOINT CHANGES AFTER WHIPLASH TRAUMA - A PROSPECTIVE-STUDY USING MR-IMAGING, American journal of roentgenology, 171(5), 1998, pp. 1237-1243
Authors:
ANDERSSON F
HOLM HJ
Citation: F. Andersson et Hj. Holm, TRANSPARENCY PREFERENCE AND ECONOMIC-BEHAVIOR, Journal of economic behavior & organization, 37(3), 1998, pp. 349-356
Authors:
ANDERSSON F
EDGAR SB
Citation: F. Andersson et Sb. Edgar, CURVATURE-FREE ASYMMETRIC METRIC CONNECTIONS AND LANCZOS POTENTIALS IN KERR-SCHILD SPACETIMES, Journal of mathematical physics, 39(5), 1998, pp. 2859-2861
Authors:
ERHARDT L
BALL S
ANDERSSON F
Citation: L. Erhardt et al., COST-EFFECTIVENESS IN THE TREATMENT OF HEART-FAILURE WITH RAMIPRIL - A SWEDISH SUBSTUDY OF THE AIRE STUDY (VOL 12, PG 256, 1997), PharmacoEconomics, 12(6), 1997, pp. 706-706
Authors:
ERHARDT L
BALL S
ANDERSSON F
BERGENTOFT P
MARTINEZ C
Citation: L. Erhardt et al., COST-EFFECTIVENESS IN THE TREATMENT OF HEART-FAILURE WITH RAMIPRIL - A SWEDISH SUBSTUDY OF THE AIRE STUDY, PharmacoEconomics, 12(2), 1997, pp. 256-266
Authors:
WAAGSTEIN F
ANDERSSON F
Citation: F. Waagstein et F. Andersson, COST-EFFECTIVENESS OF METOPROLOL IN IDIOPATHIC DILATED CARDIOMYOPATHY, Journal of the American College of Cardiology, 29(2), 1997, pp. 17144-17144
Authors:
SWAHN BM
ANDERSSON F
PELCMAN B
SODERBERG J
CLAESSON A
Citation: Bm. Swahn et al., SYNTHESIS OF C-14-LABELED -DIMETHYL-3-(PHOSPHONOMETHYL)-2-QUINOLINEPROPANOIC ACID, Journal of labelled compounds & radiopharmaceuticals, 39(3), 1997, pp. 259-266
Authors:
ANDERSSON F
Citation: F. Andersson, SMALL POLLUTION MARKETS - TRADABLE PERMITS VERSUS REVELATION MECHANISMS, Journal of environmental economics and management, 32(1), 1997, pp. 38-50
Authors:
KARTMAN B
ANDERSSON F
JOHANNESSON M
Citation: B. Kartman et al., WILLINGNESS-TO-PAY FOR REDUCTIONS IN ANGINA-PECTORIS ATTACKS, Medical decision making, 16(3), 1996, pp. 248-253
Authors:
ANDERSSON F
EDGAR SB
Citation: F. Andersson et Sb. Edgar, THE WAVE-EQUATIONS FOR THE WEYL TENSOR SPINOR AND DIMENSIONALLY DEPENDENT TENSOR IDENTITIES/, International journal of modern physics D, 5(3), 1996, pp. 217-225
Authors:
ANDERSSON F
Citation: F. Andersson, INCOME TAXATION AND JOB-MARKET SIGNALING, Journal of public economics, 59(2), 1996, pp. 277-298
Authors:
ANDERSSON F
KARTMAN B
Citation: F. Andersson et B. Kartman, THE COST OF ANGINA-PECTORIS IN SWEDEN, PharmacoEconomics, 8(3), 1995, pp. 233-244
Authors:
ANDERSSON F
Citation: F. Andersson, WHY IS THE PHARMACEUTICAL-INDUSTRY INVESTING INCREASING AMOUNTS IN HEALTH ECONOMIC EVALUATIONS, International journal of technology assessment in health care, 11(4), 1995, pp. 750-761
Authors:
SIMPSON K
HATZIANDREU EJ
ANDERSSON F
SHAKESPEARE A
OLEKSY I
TOSTESON ANA
Citation: K. Simpson et al., COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT WITH ZALCITABINE PLUS ZIDOVUDINE FOR AIDS PATIENTS WITH CD4-THAN 300( COUNTS LESS)MU-1 IN 5 EUROPEAN COUNTRIES/, PharmacoEconomics, 6(6), 1994, pp. 553-562
Authors:
ANDERSSON F
Citation: F. Andersson, THE DISTRIBUTION OF PHARMACEUTICALS IN EUROPE - CURRENT AND FUTURE-TRENDS IN WHOLESALING, Health policy, 27(3), 1994, pp. 271-292
Authors:
ANDERSSON F
Citation: F. Andersson, METHODOLOGICAL ASPECTS OF INTERNATIONAL DRUG PRICE COMPARISONS, PharmacoEconomics, 4(4), 1993, pp. 247-256
Risultati:
1-17
|